MH · McGraw Hill Inc. Common Stock
View on chartInsiders & Stakes
| Philip D. Moyer See Remark | ▲ Buy | Open Market | 516,768 Shares held | 6/15/2026 | View profile |
| David B. Stafford EVP, GC & Secretary | ▲ Buy | Grant | 100,774 Shares held | 4/1/2026 | View profile |
| Robert Sallmann EVP & CFO | ▲ Buy | Grant | 89,842 Shares held | 4/1/2026 | View profile |
| David Cortese EVP & CDIO | ▲ Buy | Grant | 44,605 Shares held | 4/1/2026 | View profile |
| Tracey Tiska EVP & CHRO | ▲ Buy | Grant | 40,842 Shares held | 4/1/2026 | View profile |
| Felicia Alvaro Director | ▲ Buy | Grant | 26,968 Shares held | 8/11/2026 | View profile |
| Steven Reinemund Director | ▲ Buy | Grant | 26,968 Shares held | 8/11/2026 | View profile |
| Guhan Subramanian Director | ▲ Buy | Grant | 26,968 Shares held | 8/11/2026 | View profile |
| Simon Jonathan Allen | ▲ Buy | Grant | 16,086 Shares held | 8/11/2026 | View profile |
| Van Dam Brian Keith Chief Accounting Officer | ▲ Buy | Grant | 8,473 Shares held | 4/1/2026 | View profile |
| Mary Ann Sigler Director | ▲ Buy | Open Market | 7,500 Shares held | 7/25/2025 | View profile |
Transaction History
| Guhan Subramanian | ▲ Buy | Grant | 16,086 | $0 | 8/11/2026 |
| Felicia Alvaro | ▲ Buy | Grant | 16,086 | $0 | 8/11/2026 |
| Steven Reinemund | ▲ Buy | Grant | 16,086 | $0 | 8/11/2026 |
| Simon Jonathan Allen | ▲ Buy | Grant | 16,086 | $0 | 8/11/2026 |
| Philip D. Moyer | ▲ Buy | Open Market | 22,421 | $249K | 6/15/2026 |
| Tracey Tiska | ▲ Buy | Grant | 36,842 | $0 | 4/1/2026 |
| Van Dam Brian Keith | ▲ Buy | Grant | 8,473 | $0 | 4/1/2026 |
| David B. Stafford | ▲ Buy | Grant | 36,842 | $0 | 4/1/2026 |
| Robert Sallmann | ▲ Buy | Grant | 86,842 | $0 | 4/1/2026 |
| David Cortese | ▲ Buy | Grant | 42,105 | $0 | 4/1/2026 |
| Steven Reinemund | ▲ Buy | Open Market | 58,000 | $795K | 2/17/2026 |
| Philip D. Moyer | ▲ Buy | Grant | 108,381 | $1.5M | 2/17/2026 |
| Philip D. Moyer | ▲ Buy | Grant | 108,381 | $0 | 2/17/2026 |
| Philip D. Moyer | ▲ Buy | Grant | 277,585 | $0 | 2/9/2026 |
| Steven Reinemund | ▲ Buy | Open Market | 15,710 | $236K | 11/14/2025 |
| David Cortese | ▲ Buy | Open Market | 2,500 | $43K | 7/25/2025 |
| Tracey Tiska | ▲ Buy | Open Market | 4,000 | $68K | 7/25/2025 |
| Robert Sallmann | ▲ Buy | Open Market | 3,000 | $51K | 7/25/2025 |
| Mary Ann Sigler | ▲ Buy | Open Market | 7,500 | $128K | 7/25/2025 |
| Steven Reinemund | ▲ Buy | Grant | 10,882 | $0 | 7/23/2025 |
| Guhan Subramanian | ▲ Buy | Grant | 10,882 | $0 | 7/23/2025 |
| Felicia Alvaro | ▲ Buy | Grant | 10,882 | $0 | 7/23/2025 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
McGraw Hill Completes Refinancing, Sets Q2 Earnings Date
McGraw Hill has successfully completed its refinancing transactions, a move that helps manage the company's debt structure. The company also announced it will release its fiscal second-quarter 2027 results on November 5, 2026. While the stock is currently trading near its 52-week high, analysts continue to monitor the impact of private equity involvement on the business.
McGraw Hill Completes Refinancing, Sets Q2 Earnings Date. McGraw Hill has successfully completed its refinancing transactions, a move that helps manage the company's debt structure. The company also announced it will release its fiscal second-quarter 2027 results on November 5, 2026. While the stock is currently trading near its 52-week high, analysts continue to monitor the impact of private equity involvement on the business.